Assetmark Inc. grew its position in Smith & Nephew plc (NYSE:SNN) by 1,040.9% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 80,341 shares of the medical equipment provider’s stock after buying an additional 73,299 shares during the period. Assetmark Inc.’s holdings in Smith & Nephew were worth $3,498,000 as of its most recent SEC filing.
Other institutional investors have also recently bought and sold shares of the company. LS Investment Advisors LLC acquired a new stake in shares of Smith & Nephew in the 2nd quarter valued at $31,000. Advisory Services Network LLC grew its position in shares of Smith & Nephew by 132.7% in the 2nd quarter. Advisory Services Network LLC now owns 819 shares of the medical equipment provider’s stock valued at $36,000 after buying an additional 467 shares during the last quarter. Oakworth Capital Inc. purchased a new position in shares of Smith & Nephew in the 2nd quarter valued at $42,000. SRS Capital Advisors Inc. purchased a new position in shares of Smith & Nephew in the 2nd quarter valued at $54,000. Finally, Pacer Advisors Inc. purchased a new position in shares of Smith & Nephew in the 2nd quarter valued at $69,000. 8.76% of the stock is owned by institutional investors and hedge funds.
SNN has been the topic of several analyst reports. Zacks Investment Research raised shares of Smith & Nephew from a “hold” rating to a “buy” rating and set a $49.00 target price on the stock in a report on Tuesday, July 2nd. Berenberg Bank upgraded shares of Smith & Nephew from a “hold” rating to a “buy” rating in a research note on Tuesday, July 23rd. Four investment analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average price target of $27.50.
NYSE SNN opened at $47.96 on Friday. The company’s fifty day simple moving average is $47.23 and its 200-day simple moving average is $43.20. The company has a debt-to-equity ratio of 0.40, a current ratio of 2.00 and a quick ratio of 0.96. Smith & Nephew plc has a 52 week low of $32.22 and a 52 week high of $48.93.
The business also recently declared a — dividend, which will be paid on Wednesday, October 30th. Investors of record on Friday, October 4th will be issued a $0.288 dividend. The ex-dividend date is Thursday, October 3rd. This represents a yield of 1.5%. Smith & Nephew’s dividend payout ratio is presently 42.57%.
Smith & Nephew Profile
Smith & Nephew plc develops, manufactures, and sells medical devices worldwide. The company offers sports medicine joint repair products for surgeons, including an array of instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder.
Featured Story: What is the 52-week high/low?
Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.